Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Ascom appoints David Hale as new CEO
-
European Commission approves Roche’s Gazyva/Gazyvaro for adults with active lupus nephritis
-
Net Asset Value of EfTEN Real Estate Fund AS as of 30 November 2025
-
Arcadis reports transactions under its current share buyback program
-
On The Go TV Launches Streaming Platform Amid Evolving Consumer Preferences
-
2025 Assessment Finds U.S. Cities Are Taking Action to Advance Health Policy; 11 Improve Overall Medal Status
-
Responding to Change through Reform Pursuing Development through Transformation, 2025 Imperial Springs Int'l Forum Concludes with In-Depth Discussions on Global Economic Trends
-
Nantong, Jiangsu: E-commerce Training Helps Enterprises Enhance Digital Marketing and Cross-border Operations
-
Daedalus Special Acquisition Corp. Announces the Upsized Pricing of $225 Million Initial Public Offering
-
The Collegiate Cricket League Announces The 2026 Collegiate Cup® Location at Broward County Cricket Stadium
-
2025 Greater Bay Area Science Forum Kicks Off in Guangzhou, Focusing on Industry-Research Synergy
-
Minim Martap Development Update
-
Latest Data of InnoCare’s Novel BCL2 Inhibitor Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)
-
Netcapital Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Cygnus Metals Limited: Issue of Performance Rights
-
EnWave to Report Fourth Quarter and Annual 2025 Financial Results on December 15, 2025 and Host Investor Conference Call
-
Monument Mining Announces Results of Annual General Meeting of Shareholders
-
ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment
-
ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib in Newly Diagnosed Ph+ ALL Shows a Best MRD-Negativity CR Rate Exceeding 60%
-
ASH 2025 | Ascentage Pharma Presents Four-Year Follow-Up Data from Registrational Phase II Study of Olverembatinib, Reaffirming Differentiated Long-Term Efficacy and Safety in TKI-Resistant/Intolerant
-
RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO
-
Star Group, L.P. Reports Fiscal 2025 Full Year and Fourth Quarter Results
-
UPDATE - Broadway Star Morgan Dudley Joins Stargaze as Creative Advisor
-
AI UltraProd Announces U.S. Market Entry with Strategic Focus on High-Growth ADU Sector
-
Imviva Biotech Presents Validating Data for CAR-T Cell Therapies CTD402 and CTA311 in Five Presentations at the 67th American Society of Hematology Annual Meeting
-
UPDATED: TDECU Adds Two New Members to Board of Directors
-
Transocean Ltd. Announces $130 Million Award for Ultra-Deepwater Drillship
-
Imviva Biotech Presents Clinical Breakthroughs for CTD402 in High-Mortality T-Cell and Myeloid Leukemias at the 67th American Society of Hematology Annual Meeting
-
Mawson Receives Final Order for Arrangement with First Nordic Metals
-
IREN Closes $2.3 Billion Convertible Notes Offering and the Repurchase of Existing Convertible Notes
-
Veterans Healing Journey Becomes Soundtrack of Thrive Dispensaries
-
SKG Unveils Top Tech Wellness Gifts for Christmas 2025 – Revolutionary Neck & Foot Massagers for Instant Pain Relief
-
TEN Ltd. Receives Best Deal of the Year Award at the 2025 Lloyds List Greek Shipping Awards
-
Interfor Announces Appointment of Chief Financial Officer; Chief Operating Officer
-
Netcapital Inc. Announces Appointment of Rich Wheeless as CEO
-
SKG Unveils Top Tech Wellness Gifts for Christmas 2025 – Revolutionary Neck & Foot Massagers for Instant Pain Relief
-
Nayax Announces Preliminary Results of Notes and Warrants Offering in Israel to Qualified Investors
-
Capstone Infrastructure Corporation and Wei Wai Kum First Nation Announce Renaming and New Artwork for Yəyus Energy
-
Aeroméxico November 2025 Traffic Results
-
Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting
-
United Community Banks, Inc. Announces Extension of Share Repurchase Program
-
Hungry Hippo Fairing Successfully Qualified: Rocket Lab Clears Significant Milestone on Path to First Neutron Launch
-
FG Nexus Further Enhances Governance and Appoints Scott D. Wollney as Lead Independent Director
-
Toll Brothers Reports FY 2025 Fourth Quarter Results
-
Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)
-
Roche presents Lunsumio data showing potential across earlier treatment lines in indolent and aggressive lymphomas
-
Vornado Declares Common Dividend of $.74 Per Share
-
Arizona State Card Show Will Have $50 Million Worth of Sports and Pokemon Cards On Display
-
Microchip Technology to Present at the Barclays 23rd Annual Global Technology Conference
-
Latham Group Appoints Sean Gadd as Chief Executive Officer
